Advertisement Press Releases Archive - Page 6 of 233 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

Search

  • 03 Nov 2023
    Safety First: Tosoh Bioscience Transforms Gene Therapy with Innovative AAV Analysis Technique

    Safety First: Tosoh Bioscience Transforms Gene Therapy with Innovative AAV Analysis Technique

    By Nat Schaefer

    Tosoh Bioscience, a renowned leader in the field of chromatography, announced the recent publication of a groundbreaking paper titled 'Separation of Full and Empty AAV Capsids by Anion-Exchange Chromatography Using Choline-Type Salts'. The research, made accessible to the scientific community through SSRN/Elsevier as a pre-print publication, spotlights an innovative analytical method for professionals working with adeno-associated viruses (AAVs) that ensures a safer working environment and environmental protection. The method uses non-toxic choline chloride for the separation of empty and full AAV capsids, marking a significant improvement in comparison with the traditionally used, and highly toxic, tetramethylammonium chloride (TMAC).

  • 18 Oct 2023
    Gerresheimer Awarded EcoVadis Gold Status Again

    Gerresheimer Awarded EcoVadis Gold Status Again

    By Nat Schaefer

    Gerresheimer, an innovative provider of systems and solutions and a global partner for the pharma, biotech and cosmetic industries, has once again been awarded Gold status by the ratings agency EcoVadis. EcoVadis assesses the performance of businesses on environmental, labour and human rights, ethical, and sustainable procurement criteria.

  • 12 Oct 2023
  • 11 Oct 2023
  • 09 Oct 2023
    Gerresheimer on Track to Another Strong Financial Year

    Gerresheimer on Track to Another Strong Financial Year

    By Nat Schaefer

    Gerresheimer, innovative provider of systems and solutions and global partner for the pharma, biotech, and cosmetics industries, made progress toward another strong financial year and a sustained improvement in profitability in the first nine months of 2023. Revenue grew organically (excluding exchange rate effects) by 12.6% year on year in the first nine months.

  • 05 Oct 2023
  • 02 Oct 2023
    Gerresheimer Gx Elite Vials: Safely Putting Production in the Fast Lane

    Gerresheimer Gx Elite Vials: Safely Putting Production in the Fast Lane

    By Nat Schaefer

    Gerresheimer, an innovative system and solution provider and a global partner for the pharma and biotech industry, is launching Gx Elite, a product line of glass injection vials designed to maximise patient safety and production efficiency. Top quality and shatter resistance are the key priorities of the range. The advanced primary packaging solution is particularly suitable for sophisticated drugs such as biopharmaceuticals and cytostatics.

  • 28 Sep 2023
  • 27 Sep 2023
    Gerresheimer at CPHI: Focus on High-Value Solutions and Sustainability

    Gerresheimer at CPHI: Focus on High-Value Solutions and Sustainability

    By Nat Schaefer

    Gerresheimer, an innovative system and solution provider and a global partner for the pharma and biotech industry, will present its extensive portfolio of containment solutions, drug delivery systems and digital solutions in areas such as therapy support at this year’s CPHI Barcelona. The company’s presence at the trade fair will focus on specialised primary packaging solutions for sensitive innovative drugs such as biopharmaceuticals, cell and gene therapy products — from COP injection vials for cryogenic temperatures starting at -80°C through to medication pumps.

  • 20 Sep 2023
«‹45678›»